A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
Active, not recruiting · NCT04554914 · Registry updated 2026-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases | DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, inborn error of immunity, leiomyosarcoma, lymphatic system disorder, lymphoproliferative syndrome, myomatous neoplasm, neoplasm, sarcoma, viral infectious disease | Active, not recruiting | Phase 2 | 2026-07-31 | NCT04554914 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pierre Fabre Medicament | 14 |
40 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.